首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.
【2h】

Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

机译:区分人类套膜区和边缘区B细胞的两种单克隆抗体(UCL4D12和UCL3D3)的特征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two new monoclonal antibodies (MoAbs), UCL3D3 and UCL4D12 were obtained following immunization with follicular lymphoma (UCL3D3) or low-grade primary B cell gastric lymphoma cells (UCL4D12). In normal splenic white pulp, tonsil and small intestinal Peyer's patches, UCL4D12 recognizes marginal zone B cells and a subpopulation of follicle centre cells, whereas mantle zone B cells are UCL4D12 negative. In contrast, UCL3D3 recognizes mantle zone B cells and follicular dendritic cells, but not marginal zone B cells or follicle centre B cells. Double-immunofluorescence studies showed that in the splenic white pulp, these antibodies stain reciprocally. The majority of UCL3D3+ cells are sIgM+ and sIgD+ whereas a higher proportion of UCL4D12+ cells express surface IgM (sIgM) but not surface IgD (sIgD). Less than 10% of splenic B cells express both 3D3 and 4D12 antigens. None of the cell lines tested expressed either antigen. Functional studies showed that both antigens play a role in B cell activation as the MoAbs increase the mitogenic effect of Staphylococcus aureus Cowan I on tonsil B cells. This effect was maximal at 72 h in culture. TPA activation was reduced, and no effect was observed with anti-immunoglobulin (anti mu) or CDw40 (G28.5). UCL3D3 and UCL4D12 did not show any stimulatory effect on their own. Biochemical studies show that both MoAbs recognize proteins of 80-90 kD under reducing conditions. These two MoAbs appear to recognize new B cell surface antigens which may be useful for identifying subpopulations of B cells.
机译:用滤泡性淋巴瘤(UCL3D3)或低度原发性B细胞胃淋巴瘤细胞(UCL4D12)免疫后,获得了两种新的单克隆抗体(MoAbs)UCL3D3和UCL4D12。在正常的脾脏白髓,扁桃体和小肠Peyer斑块中,UCL4D12识别边缘B区细胞和滤泡中心细胞亚群,而套层B细胞UCL4D12阴性。相反,UCL3D3识别套膜B区细胞和滤泡树突状细胞,但不能识别边缘B区细胞或滤泡中心B细胞。双重免疫荧光研究表明,在脾脏的白色纸浆中,这些抗体相互染色。大多数UCL3D3 +细胞为sIgM +和sIgD +,而较高比例的UCL4D12 +细胞表达表面IgM(sIgM),但不表达表面IgD(sIgD)。少于10%的脾B细胞同时表达3D3和4D12抗原。测试的细胞系均未表达任何一种抗原。功能研究表明,两种抗原都在MoAb的B细胞活化中起作用,因为MoAb增强了金黄色葡萄球菌Cowan I对扁桃体B细胞的促有丝分裂作用。此效应在培养72 h时最大。 TPA激活降低,并且抗免疫球蛋白(anti mu)或CDw40(G28.5)未观察到作用。 UCL3D3和UCL4D12本身没有显示任何刺激作用。生化研究表明,两种MoAb在还原条件下均可识别80-90 kD的蛋白质。这两个MoAb似乎识别新的B细胞表面抗原,这可能对鉴定B细胞亚群有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号